Pages that link to "Q39019431"

The following pages link to SUMOylation proteins in breast cancer (Q39019431):

Displaying 19 items.

• Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention (Q26314693) (← links)
• Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications (Q35380380) (← links)
• Identification of c-MYC SUMOylation by mass spectrometry (Q35529775) (← links)
• Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response (Q35678658) (← links)
• KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer (Q36086823) (← links)
• A Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle (Q36333305) (← links)
• Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. (Q36369146) (← links)
• Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges (Q38255299) (← links)
• Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells (Q38262063) (← links)
• Posttranslational modifications of lysine and evolving role in heart pathologies-recent developments (Q38272115) (← links)
• SUMO pathway components as possible cancer biomarkers (Q38515816) (← links)
• Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer (Q38900933) (← links)
• Protein microarray applications: Autoantibody detection and posttranslational modification. (Q38907014) (← links)
• The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways (Q38907680) (← links)
• Wanted DEAD/H or Alive: Helicases Winding Up in Cancers. (Q38998990) (← links)
• Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers (Q41081937) (← links)
• Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein (Q42496885) (← links)
• Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer. (Q50437809) (← links)
• Association of SENPs single-nucleotide polymorphism and breast cancer in Chinese population (Q64257306) (← links)